Coronavirus Disease 2019-Related Stigma in China: A Descriptive Study

Li Zhao1, Zhen Wang1, Jian Guan1

  • 1Department of Social Psychology, Zhou Enlai School of Government, Nankai University, Tianjin, China.

Frontiers in Psychology
|August 30, 2021
PubMed

Insights

This study quantifies COVID-19 stigma in China, revealing significant prejudice against recovered patients, their families, high-risk individuals, and healthcare workers. Greater COVID-19 knowledge generally reduces stigma, but not for those already stigmatizing others.

Area of Science:

  • Public Health
  • Social Psychology
  • Epidemiology

Background:

  • Coronavirus disease 2019 (COVID-19) has had profound global health impacts.
  • Most COVID-19 research focuses on medical aspects, neglecting social dimensions like stigma.
  • Quantitative data on COVID-19-related stigma in China is limited.

Purpose of the Study:

  • To investigate and quantify the prevalence of COVID-19-related stigma among individuals in China.
  • To explore the relationship between COVID-19 knowledge and stigma.
  • To identify specific groups targeted by COVID-19 stigma.

Main Methods:

  • An online survey was conducted with 1,920 Chinese participants between October and December 2020.
  • Data on perceived stigma towards various groups (high-risk individuals, recovered patients, families, healthcare providers) were collected.
  • Knowledge about COVID-19 was assessed to determine its association with stigma.

Main Results:

  • Significant proportions of participants endorsed stigma: 15.94% towards high-risk areas, 14.84% towards recovered patients, 13.80% towards families of recovered patients, and 5.21% towards frontline healthcare providers.
  • General COVID-19 knowledge was negatively associated with overall stigma.
  • No significant association was found between COVID-19 knowledge and stigma among individuals already holding stigmatizing views.

Conclusions:

  • COVID-19-related stigma is prevalent in China, affecting recovered patients, their families, individuals in high-risk areas, and healthcare workers.
  • Public health interventions should address knowledge gaps and combat discriminatory attitudes to mitigate COVID-19 stigma.
  • Findings offer a quantitative basis for developing targeted anti-stigma strategies globally.

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
833
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.9K
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
319